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Abstract: OBJECTIVE To investigate the course of temporomandibular joint (TMJ) inflammation,
osseous deformation and mandibular ramus growth in children with juvenile idiopathic arthritis (JIA)
during systemic therapy. METHODS Longitudinal study of 38 consecutive JIA patients (29 female,
median age 9.0 years, interquartile range 6.2 to 10.7 years) on systemic therapy with TMJ involvement,
with two TMJ magnetic resonance imaging (MRI) examinations ฀ 2 years apart and no TMJ corticosteroid
injection. Clinical and MRI findings were compared between initial and follow-up examinations and
between TMJs with and without active inflammation at baseline. RESULTS Over a median period of
3.6 years (range, 2.0-8.7 years), MRI grade of TMJ inflammation improved (p=0.009) and overall osseous
deformity tended to become less severe (p=0.114). In TMJs with arthritis at baseline (46 TMJs), both
the grades of inflammation (p<0.001) and deformity (p=0.011) improved. In TMJs with no arthritis
at baseline (30 TMJs), the frequency and grade of condylar deformation remained stable. Mandibular
ramus growth rates were not significantly different between TMJs with and without arthritis at baseline
(1.3 mm/year versus 1.5 mm/year, p=0.273), and were not correlated with the degree of inflammation at
baseline or followup. The frequency of facial asymmetry tended to be lower at follow-up than at initial
examination (24% versus 45%, p=0.056). CONCLUSION Our results suggest that systemic treatment of
TMJ arthritis in children with JIA decreases the degree of inflammation seen on MRI, preserves osseous
TMJ morphology and maintains normal mandibular ramus growth.
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To investigate the course of temporomandibular joint (TMJ) inflammation, osseous deformation and 
mandibular ramus growth in children with juvenile idiopathic arthritis (JIA) during systemic therapy.
Methods.
Longitudinal study of 38 consecutive JIA patients (29 female, median age 9.0 years, interquartile range 6.2 to 
10.7 years) on systemic therapy with TMJ involvement, with two TMJ magnetic resonance imaging (MRI) 
examinations ≥ 2 years apart and no TMJ corticosteroid injection. Clinical and MRI findings were compared 
between initial and follow-up examinations and between TMJs with and without active inflammation at 
baseline.
Results.
Over a median period of 3.6 years (range, 2.0–8.7 years), MRI grade of TMJ inflammation improved (p=0.009) 
and overall osseous deformity tended to become less severe (p=0.114). In TMJs with arthritis at baseline (46 
TMJs), both the grades of inflammation (p<0.001) and deformity (p=0.011) improved. In TMJs with no arthritis 
at baseline (30 TMJs), the frequency and grade of condylar deformation remained stable. Mandibular ramus 
growth rates were not significantly different between TMJs with and without arthritis at baseline (1.3 mm/year 
versus 1.5 mm/year, p=0.273), and were not correlated with the degree of inflammation at baseline or follow-
up.The frequency of facial asymmetry tended to be lower at follow-up than at initial examination (24% versus 
45%, p=0.056).
Conclusion.
Our results suggest that systemic treatment of TMJ arthritis in children with JIA decreases the degree of 
inflammation seen on MRI, preserves osseous TMJ morphology and maintains normal mandibular ramus 
growth. 
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Introduction
Involvement of the temporomandibular joint (TMJ) is common in patients with juvenile idiopathic arthritis (JIA), 
with an estimated frequency of about 40 - 60% based on large imaging series in the literature (1, 2). As 
inflammation of the TMJ is suspected to be the cause for craniofacial growth disturbances frequently seen in 
patients with JIA (3), early detection and prompt treatment of arthritis is currently thought to be essential for 
normal development of the TMJ and mandible in growing children.
Because TMJ arthritis may often be asymptomatic and difficult to diagnose clinically (4, 5), contrast-enhanced 
magnetic resonance imaging (MRI) is considered the best available method for early diagnosis (6). In addition, 
MRI allows for grading the level of inflammation in the TMJ as well as assessment of the osteochondral joint 
morphology and height of the mandibular ramus (7-9).
Our group has previously shown that intraarticular corticosteroid injections in a cohort of 33 children with JIA 
did neither preserve normal growth of the mandibular ramus over a median period of 5 years, nor were they 
able to prevent progressive TMJ deformity (10).
With this study, we aimed to evaluate mandibular growth, the course of inflammation and deformity of the 
TMJ in children who underwent systemic immunosuppressive treatment for JIA.
Material and Methods
Patients
For this retrospective study, we identified 38 consecutive children seen at our tertiary paediatric university 
hospital between 2006 and 2015 with a diagnosis of JIA according to the International League of Associations 
for Rheumatology 2001 criteria (11), MRI diagnosis of TMJ involvement (TMJ arthritis and/or TMJ deformity 
presumed to be the result of arthritis) and an MRI follow-up after 2 or more years. During this period, we saw 
479 JIA patients in our outpatient clinics and MRI was performed routinely at a time point when TMJ 
involvement had a potential implication for treatment (12). Patients without systemic immunosuppressive 
treatment and those who received any corticosteroid injections in the TMJ were excluded from the study. 
Children with no consent for retrospective data analysis were not considered. The study was conducted 
according to Swiss legislation and approved by the governmental research ethics committee (KEK ZH 2015-
0433).
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Patient data, including results of clinical examinations and medication during the observation period, were 
retrieved from the electronic patient files. The study population consisted of 29 girls and 9 boys, with a median 
age of 9.0 years at first MRI (age range 1.5 – 13.7 years, IQR 6.2 – 10.7 years) and a median age of 6.8 years at 
initial diagnosis of JIA (age range 1.2 - 12.8 years, IQR 3.3 – 9.0 years). The follow-up MRI evaluated for this 
study was performed after a median interval of 3.6 years (range 2.0 – 8.7 years, IQR 2.6 – 4.7 years). The 
patient characteristics of the study population are summarised in table 1. The terminology used in this work 
adheres to the recommendations by the TMJ juvenile arthritis working group (13).
Clinical examination
Clinical assessment of the TMJ was performed as routine care at regular intervals by experienced paediatric 
rheumatologists and orthodontists (14). Results of the examination closest to the respective MRI were used for 
this study (median interval between clinical assessment and MRI 0 days, IQR -2.2 to 0.8 months). Presence of 
TMJ pain as reported by the patient and on palpation in a relaxed position of the mandible and during 
movement was noted. Mandibular skeletal asymmetry was graded as absent (0), mild (± 1) or severe (± 2) with 
a deviation to the right (positive value) or to the left (negative value). Maximal mouth opening capacity (MOC), 
i.e. the unassisted greatest inter-incisal distance without adjustment for overbite, was measured with an acrylic 
ruler after the patient opened the mouth as wide as possible several times for warm-up. Centiles of MOC were 
calculated from normal age- and gender- adjusted values (15).
MRI evaluation
All contrast-enhanced MRI of the TMJ was performed at 1.5 Tesla (Signa MR/i Twinspeed or Discovery MR450, 
GE Medical Systems, Milwaukee, USA) with a TMJ surface coil in closed mouth position according to the 
institutional protocol (10). The MRI studies were reviewed by an orthodontist (AB) and a paediatric radiologist 
(CJK) in a consensus reading. As described previously (8, 10), TMJ involvement was graded with a progressive 
scoring system (Appendix). Presence and degree of joint effusion, synovial thickening, and bone marrow 
oedema were assessed on fat-saturated T2-weighted images. Presence and extension of joint enhancement 
was assessed on early contrast-enhanced images. Inflammatory activity of the TMJ was graded semi 
quantitatively on a 5-grade scale (grades 0–4). Shape and integrity of the temporal bone (articular eminence 
and glenoid fossa) and mandibular condyle were assessed on gradient echo images. Osseous deformity was 
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also graded semi quantitatively on a 5-grade scale. Mandibular ramus height was measured on minimum 
intensity projection images from a three-dimensional (3D) gradient echo sequence, on a line parallel to the 
posterior border of the ramus through the most cranial point of the condyle to the intersection with the 
inferior border of the ramus (9) . From the mandibular height at the initial MRI and follow-up MRI, growth rates 
were calculated for each mandibular ramus, and compared to normal age- and gender-matched growth rates 
based on longitudinal cephalographic measurements between the condylion and gonion in 102 children from 3 
to 16 years of age (16, 17).
Comparisons and statistical analysis
Descriptive data are given as mean ± standard deviation for continuous variables with normal distribution and 
as median (interquartile range) for variables without normal distribution. Normal distribution of the data was 
checked with the Shapiro-Wilk test. Frequencies are reported as fractions (percentage).
The clinical findings were compared between initial and follow-up examination with the chi squared test for 
frequencies, Wilcoxon test for ordinal and not normally distributed data, and paired sample t-test for data with 
normal distribution. TMJ pain, MOC and facial asymmetry were correlated to MRI findings with Spearman rank 
correlation.
The MRI findings were compared between initial and follow-up studies for TMJs with and without active 
inflammation at baseline, and between TMJs with and without active inflammation at baseline.
Frequencies of MRI findings at initial and follow-up examinations were compared with the chi squared test. 
Mandibular ramus height, grades of inflammation and grades of deformity were compared with the Wilcoxon 
test between MRI examinations. Mandibular ramus growth rates were compared between TMJs with and 
without active inflammation at baseline with the Mann-Whitney test. Measured growth rates were compared 
to expected normal growth rates with the Wilcoxon test. Growth rates were correlated with the grades of 
inflammation and deformity at initial and follow-up MRI using Spearman rank correlation. All statistical 
analyses were performed with MedCalc Statistical Software version 18.11.3 (MedCalc Software bvba, Ostend, 
Belgium). A p-value < 0.05 was considered significant.
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The indication for systemic immunosuppressive therapy was arthritis of multiple joints (n=30, peripheral joints 
and TMJs), arthritis of the spine or sacroiliac joints (n=5), or uveitis (n=2). In only one patient severe TMJ 
arthritis was the main indication for systemic treatment, at a time when we no longer offered intraarticular 
corticosteroid injections to the TMJ. Before 2013, we would have considered corticosteroid injection in the 
case of isolated TMJ arthritis or when peripheral arthritis was under control by local therapy.
In 19/38(50%) children the systemic medication was started 2.3 (IQR 4.4 to 0.9) years before the first MRI 
study. In the other half of the children, systemic medication was introduced at or after first MRI with a median 
interval of 0.5 (IQR 0.1 to 1.6) years. The median duration of systemic therapy between the initial and follow-up 
MRI was 3.0 (IQR 1.9 to 4.2) years corresponding to 96% (IQR 72% to 100%) of the observation period.
Systemic medication included methotrexate (MTX) in 35/38(92%) patients. During the observation period, MTX 
was substituted by another drug in 19/38(50%) patients: leflunomide in 9 cases, etanercept in 6 cases, 
infliximab in 2 cases, and golimumab in 2 cases. MTX or leflunomide was combined with another drug in 
20/38(53%) patients: golimumab in 9 cases, etanercept in 9 cases or tocilizumab in 2 cases. Two patients were 
treated with hydroxychloroquine and one patient with a combination of systemic corticosteroids, azathioprine 
and golimumab.
Clinical findings
The clinical findings at the initial and follow-up examinations are summarised in table 2. Tenderness was 
reported in different TMJs at baseline and at follow-up, with low frequencies of 13% and 9% respectively. 
Presence of TMJ pain did not correlate with MRI grades of inflammation or deformity. Mandibular skeletal 
asymmetry was noted in 17/38(45%) patients initially and in 9/38(23%) patients at follow-up, with resolution of 
mild asymmetry in 10 patients, but development of mild asymmetry and deterioration of mild to severe 
asymmetry in 2 patients each. Presence and degree of asymmetry were not significantly different between 
initial and follow-up examination, but the frequency of asymmetry tended to be lower at follow-up (17/38 
initially, versus 9/38 at follow-up, p=0.056). The degree of asymmetry showed a weak correlation with the 
grade of TMJ deformity (rs = 0.316, p = 0.005). The mean MOC improved by 4.4 mm (95% confidence interval 
2.7 to 6.2 mm, p<0.0001), but age- and gender-adjusted centiles of MOC were not significantly different (mean 
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difference 1.6, 95% confidence interval -6.4 to 9.7, p=0.680) between initial and follow-up assessment. Both 
absolute values and centiles of MOC showed no correlation with MRI grades of inflammation or deformity.
MRI findings
The prevalence of TMJ arthritis (active inflammation) was 27/38(71%) patients at baseline and 23/38(61%) 
patients at follow-up. TMJ deformity was seen in 22/38(59%) patients initially and in 21/38(55%) patients at 
follow-up. Initially 7/38(18%) patients had unilateral and 15/38(39%) bilateral deformity. During the study 
period, 4/38(11%) patients developed unilateral and 1/38(3%) bilateral deformity, while in 4/38(11%) patients 
unilateral deformity and in 1/38(3%) bilateral deformity resolved. In another 1/38(3%) patients bilateral 
deformity improved to unilateral deformity. Therefore the overall frequency of unilateral and bilateral 
deformity was not significantly different at follow-up: 7/38(18%) patients had unilateral and 14/38(37%) 
bilateral TMJ deformity.
At initial MRI 46/76(61%) TMJs showed signs of inflammation (grade > 0) and 37/76(49%) TMJs had some 
deformity (grade > 0). At follow-up MRI 40/76(54%) TMJs showed signs of inflammation and 35/76(46%) TMJs 
were deformed. Overall, grades of inflammation improved (p=0.009) while grades of deformation were not 
significantly different (p=0.114) at follow-up. The inflammatory and deformity grades at the initial and follow-
up MRI are detailed in table 3 for all TMJs and groups of TMJs with and without inflammation at baseline. No 
TMJ showed the most severe grade of inflammation (inflammatory activity grade 4, TMJ filled with and 
expanded by pannus), large erosions, fragmentation of the condyle or intraarticular calcification (deformity 
grade 4). 
In the TMJs without inflammation at baseline, signs of inflammation were seen at follow-up in 10/30(33%) 
TMJs, while the frequency and grades of deformation were not significantly different between initial and 
follow-up MRI.
In the TMJs with inflammation at baseline, the frequency and grades of inflammation improved significantly 
(p<0.001) at follow-up, as did the grades of deformity (p=0.011).
Inflammatory grades at follow-up MRI were lower for TMJs without inflammation at baseline than for TMJs 
with inflammation at baseline (Mann-Whitney test, p=0.018). Deformation grades were not significantly 
different between TMJs with and without inflammation at baseline both at initial (Mann-Whitney test, 
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p=0.454) and follow-up MRI (Mann Whitney test, p=0.154). The change of inflammation and deformity grades 
between initial and follow-up MRI for both groups are given in table 4. 
The height of the mandibular ramus increased by a median difference of 5.2 mm (95% confidence interval 4.5 
mm to 5.9 mm, Wilcoxon test, p<0.0001) from initial to follow-up MRI with a median growth rate of 1.4 
mm/year (95% confidence interval 1.2 mm to 1.6 mm). At both MRI studies, the mandibular ramus height was 
not significantly different between TMJs with and without inflammation or deformation at baseline (Table 5). 
The growth rates were not significantly different between TMJs with and without inflammation at baseline but 
tended to be lower in the TMJs with inflammation (median difference -0.2 mm/year, Mann-Whitney test, 
p=0.273). Overall, the observed growth rates were not significantly different from normal (Figure 1 and Table 5) 
(16, 17). TMJs with inflammation at baseline tended to have lower growth rates than normal (median 
difference - 0.15 mm/year, Wilcoxon test, p=0.140) while TMJs without inflammation at baseline showed no 
difference (median difference 0.04 mm/year, Wilcoxon test, p=0.665). The growth rate did not correlate with 
the grade of inflammation at initial or follow-up MRI, but showed a weak negative correlation with the degree 
of deformity at initial (rs=-0.257, p=0.025) and at follow-up MRI (rs=-0.399, p<0.001). 
Discussion
With this longitudinal study we describe the course of TMJ deformity, TMJ inflammation and clinical findings in 
38 children with JIA on systemic therapy over a median period of 3.6 years (range 2 – 8.7 years). Recent 
reviews have indicated that there is not much data evaluating the efficacy of contemporary systemic treatment 
on TMJ involvement in patients with JIA (18, 19). While there is anecdotal evidence that systemic therapy may 
decrease progressive radiographically evident destructive changes of the TMJ and clinically seen facial 
deformities (19), only two series observed that systemic therapy may be effective in this regard (20, 21). The 
study by Ince et al suggested that MTX therapy may minimize TMJ destruction in polyarticular JIA, because 18 
patients receiving MTX showed less severe TMJ involvement than 9 patients not receiving MTX. In a 
longitudinal study of 84 children with JIA, Twilt et al showed that the prevalence of patients with condylar 
alterations decreased from 49% to 40% over 5 years when assessed on orthopantomographs, but this 
improvement was associated with low disease activity and a less extensive therapeutic regimen (21). Before 
the widespread use of MTX therapy, Arvidsson et al observed progression of radiographic condylar and 
temporal bone abnormalities from 42% of 60 children with JIA at baseline to 65% at a 4-year follow-up 
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examination in the early 1980s (22). In our study, we found a slightly higher prevalence of condylar deformity 
at baseline (22/38 patients, 59%) which was not significantly different at follow-up (20/38 patients, 53%). The 
overall frequency and degree of TMJ deformation did not change significantly between the MRI studies, but 
TMJs with arthritis at baseline showed an improvement of the condylar deformity at follow-up (p=0.011). In 
addition, we did not observe any progressive TMJ destruction or intraarticular calcification (deformity grade 4), 
which in contrast had developed rather frequently (26% progressive TMJ destruction, 20% intraarticular 
calcification) in our previous series of 33 children treated with intraarticular corticosteroid injection (10). The 
absence of severe progressive condylar destruction in the current patients on systemic therapy may explain 
why the mandibular ramus growth rate remained normal, while it was significantly lower than normal in the 
aforementioned patients treated with TMJ corticosteroid injection.
The maintained normal mandibular ramus growth and improvement of condylar deformity in TMJs with 
arthritis at baseline may be the basis for our observation that mandibular skeletal asymmetry tended to 
decrease in the patients of the current study. This may suggest that systemic treatment could be contributory 
in preventing craniofacial deformity attributed to impaired mandibular ramus growth resulting from TMJ 
arthritis in children with JIA. Alternatively, the trend to lower facial asymmetry could just be manifestation of 
normal variation during growth (23).. The current pathophysiological assumption is that disease modifying 
antirheumatic drugs reduce inflammation in the TMJ and therefore allow for normal development of the 
condyle and growth of the mandibular ramus at the condylar growth zone. This hypothesis is supported by our 
cohort in three ways. Firstly, we found significantly less inflammation in TMJs at follow-up than at baseline. 
Secondly, mandibular ramus growth rate was negatively correlated with condylar deformity. Thirdly, the 
mandibular ramus growth rate was normal, albeit it tended to be lower in TMJs with than without 
inflammation at baseline. To our surprise, there was no correlation between the degree of inflammation seen 
on MRI and the growth of the mandibular ramus. This may indicate that TMJ arthritis was sufficiently 
controlled in our patients. However, this finding may also indicate that growth is not so much influenced by the 
inflammation per se, but growth impairment is the result of the structural damage to the growth zone of the 
mandibular condyle, which again is supported by the observed negative correlation of the growth rate with 
condylar deformity. The fact that mandibular ramus growth may be normal despite the presence of low grade 
inflammation on MRI could be used as an argument against treating TMJ arthritis aggressively with 
intraarticular corticosteroids. Another argument against intraarticular corticosteroids would be that we want to 
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avoid the risk of creating steroid-induced severe TMJ deformities because that has a negative impact on 
mandibular growth.
The clinical findings in this cohort confirm that orofacial examination has a poor diagnostic value for predicting 
the presence of TMJ arthritis (14, 24). Pain was present in only 13% and 9% of TMJs at initial and follow-up 
examination and did not correlate with MRI signs of inflammation or deformity. Overall, MOC was normal at 
initial and follow-up examination, and did not correlate with the MRI findings. Facial asymmetry was not 
significantly different between examinations but tended to improve at follow-up (p=0.056).
The main limitation of our study is its retrospective and uncontrolled design with variable medication and 
imaging intervals. From our results, it is not possible to draw any conclusions on the efficacy of different 
medications or combinations thereof. By just examining the patients at two time points, we cannot account for 
possible effects of TMJ arthritis fluctuation on the observed changes. The study cohort reflects our current 
praxis to treat JIA with systemic medication in cases with severe TMJ inflammation or when local treatment of 
other joints is not sufficient to control disease activity. MRI of the TMJ was usually conducted when the 
presence of TMJ inflammation would have changed the treatment approach or for assessing treatment 
response of confirmed TMJ arthritis. By only measuring the height of the mandibular ramus, we did not 
account for all components of vertical mandibular growth. Evaluation of appositional growth, changes in the 
gonion area, antegonial notching and backward-rotation of the mandibular corpus would require 
cephalography or three-dimensional computed tomography, which was not available in our patients. 
Nonetheless, by showing normal growth of the mandibular ramus height we assume normal condylar growth 
that is not impaired by TMJ arthritis. The use of historical cephalographic data for normal mandibular ramus 
growth is another limitation to our growth assessment. To our knowledge this is the only available data in the 
literature that allows calculation of normal mandibular ramus growth rate. The fact that the growth rates in 
both our groups of TMJs with and without arthritis at baseline did not differ from the historical normal growth 
rates suggests that they may still be accurate. 
Another limitation is the measurement error of our assessment methods, which may not allow measuring 
short-term mandibular ramus growth and change of MRI findings in the TMJ accurately in a single patient. 
According to Markic et al (9), MRI measurements of the mandibular ramus height can be performed with a 
mean difference of 0.2 mm (95% limits of agreement -2.4 – 2.9 mm). With a mean normal growth rate of 1.6 
mm/year (range 0.7 – 2.6 mm/year) (16, 17), short-term growth rates over 3 months may show a mean 
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measurement error of up to ± 50%, whereas for long-term growth rates over 5 years the mean measurement 
error is estimated at ± 5%. The grading of the TMJ inflammation and deformity was performed by two readers 
in consensus, in order to improve reliability of our assessment. The reliability of the applied grading system has 
been tested elsewhere (25) showing high reliability both for the inflammatory and deformity domain (average-
measure ICC 0.92 and 0.96) and excellent smallest detectable differences (29% and 23%). While these 
measurement errors may be substantial when assessing a single TMJ, they should be cancelled out when 
comparing mean growth rates and MRI scores of groups of joints as done in the current work.
Further studies are needed to support the portrayed findings, and should especially focus on evaluating the 
efficacy of different systemic medications and address the long term effect on TMJ morphology and overall 
craniofacial development.
In conclusion, with this retrospective longitudinal study we suggest that systemic treatment of TMJ arthritis in 
children with JIA may reduce inflammatory changes seen on MRI, preserves osseous TMJ morphology and 
maintains normal mandibular ramus growth over a period of at least 2 years. This is clearly in contrast to an 
earlier cohort treated with corticosteroid TMJ injections, in which TMJ deformity deteriorated and mandibular 
ramus growth was impaired. Our findings are also in stark contrast to the body of literature from the pre-
therapeutic era of JIA, at least with respect to growth and damage.
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Figure legends
Figure 1. Notched box and whisker plot showing the mandibular ramus growth rate in 38 patients (76 TMJs) 
during a median follow-up of 3.6 years (range 2 – 8.7 years, interquartile range 2.6 – 4.7 years) in comparison 
to the mean age- and gender-matched normal growth rate (p=0.360, Wilcoxon test). Normal growth rates were 
calculated from annual increments of cephalographic measurements between condylion and gonion in 102 
children from 3 to 16 years of age (16, 17). The central box represents the values from the lower to upper 
quartile (25th to 75th percentile), the middle line represents the median and the whiskers represent the 
minimum and maximum values with exclusion of outside values (a value that is smaller than the lower quartile 
minus 1.5 times the interquartile range or larger than the upper quartile plus 1.5 times the interquartile range).



















































 Journal of Rheumatology
The on November 15, 2019 - Published by www.jrheum.orgDownloaded from 
1
Table 1. Patient characteristics of 38 children with JIA on systemic therapy and TMJ involvement.
Patient characteristics
Female, n (%) 29 (76)
Oligoarticular, n (%) 7 (18)
Oligoarticular extended, n (%) 5 (13)
Polyarticular RF negative, n (%) 17 (45)
Enthesitis-related arthritis, n (%) 2 (5)
Psoriasis arthritis, n (%) 2 (5)
Systemic arthritis, n (%) 1 (3)
Not classified arthritis, n (%) 4 (11)
Age at diagnosis, median (IQR), years 6.8 (3.3 – 9.0)
Age at initiation of systemic medication, median (IQR), years 8.1 (4.8 – 9.9)
Age at first MRI, median (IQR), years 9.0 (6.2 – 10.7)
Disease duration at first MRI, median (IQR), years 1.2 (0.3 – 2.7)
MRI follow-up, median (IQR), years 3.6 (2.6 – 4.7)
Duration of systemic medication between MRI studies, median (IQR), years 3.0 (1.9 – 4.2)
RF rheumatoid factor, IQR interquartile range, MRI magnetic resonance imaging.
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Tenderness (76 TMJs) 10/76 (13%) 7/76 (9%) 0.432 *
Asymmetry:    Frequency













MOC,   mm (mean ± SD) 
             centiles (mean ± SD): 
44 ± 8 mm
51 ± 33




TMJ temporomandibular joint, MOC mouth opening capacity, SD standard deviation,  comparison between 
initial and follow-up examination with * chi squared test, ** Wilcoxon test, *** paired samples t-test. 
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Table 3.  MRI findings in 38 patients with JIA on systemic therapy and TMJ involvement.










































































































TMJ temporomandibular joint, comparison between MRI studies with * chi squared test, ** Wilcoxon test. 
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Table 4. Change of inflammation and deformity grades from initial to follow-up MRI in 76 TMJs of 38 patients 
with JIA on systemic therapy and TMJ involvement
TMJs without inflammation at 
baseline












TMJ temporomandibular joint, na not applicable 
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Table 5. Mandibular ramus height and growth rates in 38 patients with JIA on systemic therapy and TMJ 
involvement







At initial MRI At follow-up MRI
All TMJs (n=76) 48.5(43.3-51.8 53.9(48.1-57.9) 1.4(1.0-1.9) 1.4(1.4-1.6) 0.360
TMJs without inflammation 
at baseline (n=30)
48.0(44.1-50.7) 53.8(49.7-60.0) 1.5(1.2-2.0) 1.4(1.4-1.6) 0.665
TMJs with inflammation at 
baseline n=46)
49.1(42.4-52.3) 53.9(47.7-57.4) 1.3(1.0-1.8) 1.4(1.4-1.6) 0.140
TMJs without deformity at 
baseline (n=39)
47.8(42.4-51.7) 53.2(47.8-59.5) 1.5(1.0-2.0) 1.4(1.4-1.6) 0.734
TMJs with deformity at 
baseline (n=37)
48.8(44.5-51.9) 54(50.9-57.2) 1.3(1.1-1.7) 1.4(1.3-1.5) 0.294
Data are given as median (interquartile range), * comparison between measured growth rates and age- and 
gender matched normal growth rates with Wilcoxon test.
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Figure 1. Notched box and whisker plot showing the mandibular ramus growth rate in 38 patients (76 TMJs) 
during a median follow-up of 3.6 years (range 2 – 8.7 years, interquartile range 2.6 – 4.7 years) in 
comparison to the mean age- and gender-matched normal growth rate (p=0.360, Wilcoxon test). Normal 
growth rates were calculated from annual increments of cephalographic measurements between condylion 
and gonion in 102 children from 3 to 16 years of age (16, 17). The central box represents the values from 
the lower to upper quartile (25th to 75th percentile), the middle line represents the median and the 
whiskers represent the minimum and maximum values with exclusion of outside values (a value that is 
smaller than the lower quartile minus 1.5 times the interquartile range or larger than the upper quartile plus 
1.5 times the interquartile range). 
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Appendix. Progressive MRI score for assessing inflammatory activity and osseous deformity of the TMJ
Grade Inflammatory activity Osseous deformity
0 No inflammation:
No or small amount of joint fluid.
No enhancement or enhancement confined to 
physiological amount of joint fluid.
Normal shape of temporal bone and mandibular 
condyle:
S-shaped articular eminence/glenoid fossa.
Round condyle (young patient).
Less rounded, more angular appearing condyle (older 
patient). 
Intact and smooth subchondral bone contour. 
1 Mild inflammation: 
Extension of joint enhancement exceeds that of 
physiological joint fluid but does not involve entire 
joint compartment and/or presence of bone 
marrow oedema.
Mild flattening of mandibular condyle and/or temporal 
bone.
2 Moderate inflammation: 
Joint enhancement involves entire joint 
compartment or there is an enhancing joint 
effusion. 
Moderate flattening of mandibular condyle and/or 
temporal bone.
3 Severe inflammation: 
Detectable synovial thickening in addition to 
increased joint enhancement or effusion.
Severe flattening of mandibular condyle with loss of 
height and/or completely flat temporal bone.
± small erosions/irregularities of subchondral bone
4 Joint space filled with and expanded by pannus “Destruction” of temporomandibular joint by large 
erosions, fragmentation of mandibular condyle, 
intraarticular ossification or bone apposition on 
condyle or temporal bone.
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